Insights + opportunities for Swiss CBD manufacturers and distributors
As one of the most promising sectors in the Japanese health products market, CBD products are currently a hot topic in Japan.
The market, dominated by foreign brands, is estimated to reach 2.06 Billion CHF by 2024. However, there are some challenges to overcome, when wishing to enter the Japanese market. However, there are some challenges to overcome, when wishing to enter the Japanese market. On the one hand, Japan is attractive as a highly promising and growing market with a large health-conscious consumer group, on the other hand, its rigorous regulation of cannabis – some of the toughest in the world – means that proper preparation is required for exporters.
Our webinar on July 10, 2020 at 9h00 (CET) provides you with an overview of the opportunities and trends on the Japanese CBD market, and an explanation of the regulations and import procedures CBD manufacturers will face when exporting their products to Japan. You will also have the chance to ask our CBD experts questions at the end of the webinar.
Intro
Information
| Date | |
| Target audience | Swiss companies and companies from Liechtenstein |
| Organizer | Switzerland Global Enterprise and Swiss Business Hub Japan |
| Event language |
English |
| Place |
online webinar |
| Cost of participating | Free of charge |
Program
Speaker
Director, IT&IP Strategy Advisory Group SA / Founder, IKKYU LLC
Graduated from the University of Geneva with a PhD in law, holder of the Swiss bar certification, S-GE certified expert. Established in Japan since 2009. Business consultant and market researcher specialized in the Japan food & beverage, beauty & health market.
(IT&IP Strategy Advisory Group SA is a Swiss company. The operations of its Japan branch, located in Fukuoka, will be taken over in July 2020 by IKKYU LLC, a Japanese trading company).
CEO, ASAYAKE Inc.
Started with efforts to import CBD products from the United States in 2013, as part of activities to seek deregulation of the Japanese Cannabis Control Act, and was able to receive the required permission of the Ministry of Health, Labor and Welfare for the first time in Japan. Established ASAYAKE Inc. as a corporation in 2014. Since then, the company has continued to provide CBD oil free of charge to children with epilepsy. Currently, the main business of ASAYAKE Inc. includes import support services for foreign CBD manufacturers and wholesale to retailers. There are more than 80 retailers registered with the company.
Contact
Jacqueline Tschumi
Deputy Director & Manager APAC, Global Network + Institutional Relations
South Korea is a very dynamic market that offers Swiss companies many opportunities, particularly in the MEM...
